You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

August 19, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Zoster vaccine effective in older chemotherapy patients

Herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a new study. » Discuss efficacy of the shingles vaccine with senior patients

FDA approves new insomnia drug

FDA has approved suvorexant (Belsomra, Merck) for adults with insomnia who have difficulty falling asleep and/or staying asleep.
» Find out more about the newly approved insomnia drug

ADVERTISEMENT

Idiopathic Pulmonary Fibrosis (IPF)

IPF is the progressive formation of thick or scarred tissue in the lungs, resulting in loss of oxygen.While there is currently no known cause, continued research seeks to find an answer, alongside improved diagnosis and treatment options. Read More

EDITOR'S PICK

Guideline: Patients with liver disease should be first to receive expensive Hep C drugs

Patients with advanced liver disease or other severe symptoms of hepatitis C virus (HCV) infection should be first in line for drug therapy, according to a new guideline. » Full article

Continuing Education

MTM essentials for atrial fibrillation and drug-induced arrhythmia management

This month's article is the seventh in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review current clinical practice guidelines related to atrial fibrillation.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT08-KTF27.


Announcement: Starting this month, our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

 

Related Articles

Older adults with shingles experience more likely to ask for vaccine

FDA drug approvals-August 2014

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group